Ray Moynihan. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cyclooxygenase 2 InhibitorsDrug Industry/legislation & jurisprudenceLactonesMarketing/legislation & jurisprudencePeriodicals as Topic/legislation & jurisprudenceSulfones
Substances: See more » Cyclooxygenase 2 InhibitorsLactonesSulfonesrofecoxib
Year: 2009 PMID: 19433504 DOI: 10.1136/bmj.b1914
Source DB: PubMed Journal: BMJ ISSN: 0959-8138